82051-52-3

Basic information

• Product Name: (2S)-2,3-Dihydro-5,7-dihydroxy-2-(2-hydroxy-5-methoxyphenyl)-6,8-dimethyl-4H-1-benzopyran-4-one
• Synonyms: (2S)-2,3-Dihydro-5,7-dihydroxy-2-(2-hydroxy-5-methoxyphenyl)-6,8-dimethyl-4H-1-benzopyran-4-one;Methoxymatteucin
• CAS NO: 82051-52-3
• Molecular Formula: C18H18O6
• Molecular Weight: 0
• Mol File: 82051-52-3.mol
• Article Data: 1

Chemical Properties

• Boiling Point: 548.9°C at 760 mmHg
• Flash Point: 201.2°C
• Appearance: /
• Density: 1.377g/cm³
• Vapor Pressure: 1.16E-12mmHg at 25°C
• Refractive Index: 1.641
• CAS DataBase Reference: (2S)-2,3-Dihydro-5,7-dihydroxy-2-(2-hydroxy-5-methoxyphenyl)-6,8-dimethyl-4H-1-benzopyran-4-one(CAS DataBase Reference)
• NIST Chemistry Reference: (2S)-2,3-Dihydro-5,7-dihydroxy-2-(2-hydroxy-5-methoxyphenyl)-6,8-dimethyl-4H-1-benzopyran-4-one(82051-52-3)
• EPA Substance Registry System: (2S)-2,3-Dihydro-5,7-dihydroxy-2-(2-hydroxy-5-methoxyphenyl)-6,8-dimethyl-4H-1-benzopyran-4-one(82051-52-3)

Safety Data

• Hazardous Substances Data: 82051-52-3(Hazardous Substances Data)

Usage

InChI:InChI=1/C18H18O6/c1-8-16(21)9(2)18-15(17(8)22)13(20)7-14(24-18)11-6-10(23-3)4-5-12(11)19/h4-6,14,19,21-22H,7H2,1-3H3/t14-/m0/s1

Upstream product

• 203734-34-3 myrciacitrin II 

Relevant articles and documents

Antidiabetic principles of natural medicines. lI. Aldose reductase and α-glucosidase inhibitors from brazilian natural medicine, the leaves of Myrcia multiflora DC. (Myrtaceae): Structures of myrciacitrins I and II and myrciaphenones A and B

The methanolic extract and ethyl acetate-soluble portion from a Brazilian natural medicine, the leaves of Myrcia multiflora DC., which has been used as a specific medicine against diabetes, were found to show inhibitory activities on aldose reductase and α-glucosidase and on the increase of serum glucose level in sucrose-loaded rats and in alloxan- induced diabetic mice. From the ethyl acetate-soluble portion, new flavanone glucosides, myrciacitrins I and II, and new acetophenone glucosides, myrciaphenones A and B, were isolated together with several known compounds such as five flavonol glycosides, myricitrin, mearnsitrin, quercitrin, desmanthin-1, and guaijaverin. The structures of new compounds were determined on the basis of physicochemical and chemical evidence. The principal components of this natural medicine including new glucosides, myrciacitrin I and myrciaphenone B, were found to show potent inhibitory activities on aldose reductase and α-glucosidase.